Potential Therapeutic Aspects of Alarmin Cytokine Interleukin 33 or Its Inhibitors in Various Diseases
Autor: | Muhammad Imran Arshad, Hilal Ahmad Khan, Michel Samson, Gregory Noel, Claire Piquet-Pellorce |
---|---|
Přispěvatelé: | Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ) |
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Biomedical Research medicine.medical_treatment [SDV]Life Sciences [q-bio] Disease Immunoglobulin E diseases Mice 03 medical and health sciences 0302 clinical medicine Immune system Immunity Leukocytes medicine Genetic predisposition Alarmins Animals Humans Pharmacology (medical) Pharmacology biology business.industry Interleukin-33 3. Good health therapeutic aspects Interleukin 33 030104 developmental biology Cytokine Immunology biology.protein IL-33 business CD8 030215 immunology |
Zdroj: | Clinical Therapeutics Clinical Therapeutics, Elsevier, 2016, 38 (5), pp.1000-1016. ⟨10.1016/j.clinthera.2016.02.021⟩ Clinical Therapeutics, 2016, 38 (5), pp.1000-1016. ⟨10.1016/j.clinthera.2016.02.021⟩ |
ISSN: | 0149-2918 |
DOI: | 10.1016/j.clinthera.2016.02.021⟩ |
Popis: | International audience; Purpose The purpose of this review was to examine the comprehensively accumulated data regarding potential therapeutic aspects of exogenous administration of interleukin 33 (IL-33) or its antagonists in allergic, cancerous, infectious, and inflammatory diseases. Methods A selected review was undertaken of publications that examined the protective and exacerbating effects of IL-33 or its inhibitors in different diseases. Mechanisms of action are summarized to examine the putative role of IL-33 in various diseases. Findings IL-33 promoted antibacterial, antiviral, anti-inflammatory, and vaccine adjuvant functions. However, in TH2-biased respiratory, allergic, parasitic, and inflammatory conditions, IL-33 exhibited disease-sensitizing effects. The alarmin cytokine IL-33 induced protective effects in diseases via recruitment of regulatory T cells; antiviral CD8+ cells, natural killer cells, γδ T cells, and nuocytes; antibacterial and antifungal neutrophils or macrophages; vaccine-associated B/T cells; and inhibition of nuclear factor–κB–mediated gene transcription. In contrast, IL-33 exacerbated the disease process by increasing TH2 cytokines, IgE and eosinophilic immune responses, and inhibition of leukocyte recruitment in various diseases. Implications The protective or exacerbated aspects of use of IL-33 or its inhibitors are dependent on the type of infection or inflammatory condition, duration of disease (acute or chronic), organ involved, cytokine microenvironment, dose or kinetics of IL-33, and genetic predisposition. The alarmin cytokine IL-33 acts at cellular, molecular, and transcriptional levels to mediate pluripotent functions in various diseases and has potential therapeutic value to mitigate the disease process |
Databáze: | OpenAIRE |
Externí odkaz: |